1-2 of 2
David John Carlile
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of Glofitamab As Monotherapy and in Combination with R-ICE Chemoimmunotherapy in Children and Young Adults with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (iMATRIX-GLO)

Birgit Burkhardt, Gianluca Rossato, Mark Dixon, David John Carlile, Steven Dmytrasz, Jade Wulff, Raluca Negricea, Beate Wulff
Journal: Blood
Blood (2023) 142 (Supplement 1): 3096.
https://doi.org/10.1182/blood-2023-174929
Published: 2023
Journal Articles

New Tocilizumab (TCZ) Dosing Guidance for T-Cell Engaging Bispecific Antibody-Related Cytokine Release Syndrome (CRS) in Patients (pts) with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL): Insights from Pooled Clinical Trial Safety Experience and Quantitative Clinical Pharmacology (qCP) Analyses

Candice Jamois, David C. Turner, Leonid Gibiansky, Feifei Li, Nicolas Frey, Jean-Francois Menuet, Leonardo Roque Pereira, Linda Lundberg, Elena Guerini, David John Carlile, James Relf, Michael C. Wei, Antonia Kwan, Susan Grange
Journal: Blood
Blood (2023) 142 (Supplement 1): 1742.
https://doi.org/10.1182/blood-2023-177679
Published: 2023